🇨🇳 Article en anglais
South Korea’s embrace of GLP-1 weight-loss drugs appears particularly pronounced among younger adults, with roughly one in six Gen Z respondents reporting they had used or been prescribed the medication in 2025, according to a new report. The 2026 Korea Wellness Report, released by KB Financial Group on Sunday and cited by The Korea Times
Source : South China Morning Post. Le Fil Indépendant cite et lie cet article ; il n'en est ni l'auteur ni l'éditeur.